19:05 , Oct 6, 2017 |  BC Week In Review  |  Company News

Camino receives $10.8M grant to treat addiction

Newco Camino Pharma LLC (San Diego, Calif.) said it received a $10.8 million, three-year grant from NIH's National Institute on Drug Abuse (NIDA) which will fund a deal with Sanford Burnham Prebys Medical Research Institute...
08:00 , Feb 8, 2010 |  BioCentury  |  Politics, Policy & Law

Gene patent debate heats up

The courts, an HHS advisory committee and Congress are all considering calls to bar gene patenting in the U.S. Despite all of the attention, not much is likely to happen. Last week, a federal court...
07:00 , Apr 19, 1993 |  BioCentury  |  Strategy

Anticoagulant crowd feels squeeze

Anticoagulant crowd feels squeeze In this era of cost-consciousness, clinical efficacy may not be enough to convince hospitals and doctors to use new products, particularly in crowded fields such as anticoagulants for acute cardiovascular conditions,...
08:00 , Mar 22, 1993 |  BioCentury  |  Product Development

Second time not the charm; Angioplasty touted as alternative to tPA

Second time not the charm Gensia Pharmaceutical Inc.'s presentation at the American College of Cardiology meeting of Phase III data on Arasine in coronary artery bypass surgery failed to reassure investors, who pushed the stock...